Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director · EXECUTIVE CHAIRMAN | November 10, 2021 | December 08, 2021 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2022 | March 02, 2022 |
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date November 10, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 3,092,852 |
Ending reported balance
After 2021-11-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-10 · Gift · Disposed 693 · Balance 3,103,252 Row 2 · 2021-11-12 · Gift · Disposed 10,400 · Balance 3,092,852 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 35,789 |
Reported balance
Holding disclosure · report date 2021-11-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,789 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
CATERPILLAR INC
Report date March 01, 2022 · Filed March 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,382 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Tax withholding · Disposed 293 · Balance 8,382 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 23,286.12 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 23,286.12 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2007 Filed Feb 8, 2008 20:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 642 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 0 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| November 16, 2007 Filed Feb 8, 2008 20:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 642 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 642 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| November 16, 2007 Filed Feb 8, 2008 20:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,053,875 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,864 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,864 Underlying: common shares · 1,864 shares Expires 2009-02-11 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,878 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,878 Underlying: common shares · 1,878 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,890 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Underlying: common shares · 1,890 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 344,826 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,826 Underlying: common shares · 344,826 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 92,521 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,521 Underlying: common shares · 92,521 shares Expires 2008-09-14 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 314,796 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,796 Underlying: common shares · 314,796 shares Expires 2009-02-11 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 404,340 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 404,340 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 108,502 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: common shares · 108,502 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 362,291 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · derivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,128 Underlying: common shares · 362,291 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 757,775 | $53.60 | $40,616,740.00 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055,114 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,050 | $33.23 | $101,355.77 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,812,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 404,340 | $41.03 | $16,590,757.58 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,809,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 108,502 | $40.56 | $4,401,036.42 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 362,291 | $42.50 | $15,396,570.46 |
DisclosureSEC source: 0001104659-07-070636 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,296,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 21,698 | $52.49 | $1,138,928.02 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934,706 Read SEC document |
| February 18, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,390 | $52.49 | $440,391.10 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 956,404 Read SEC document |
| February 17, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 18,279 | $52.49 | $959,464.71 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,794 Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 550,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · derivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: common shares · 550,000 shares Expires 2017-02-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 183,334 on 2/16/08, 183,333 on 2/16/09 and 183,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 140,000 | $52.54 | $7,355,600.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,073 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 21, 2007 00:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 78,900 | $52.70 | $4,158,030.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 843,073 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 38,007 | $0.00 Strike: $47.88 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 32 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 38,007 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 23,664 | $0.00 Strike: $49.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 31 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 23,664 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,121 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,121 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 44,046 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,046 Underlying: common shares · 44,046 shares Expires 2008-09-14 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 132,148 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,148 Underlying: common shares · 132,148 shares Expires 2008-02-12 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 262,464 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,464 Underlying: common shares · 262,464 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 51,105 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,503 Underlying: common shares · 51,105 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 166,189 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875 Underlying: common shares · 166,189 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (rightto buy) · Derivative | 339,443 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · derivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 339,443 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 36,046 | $52.44 | $1,890,360.38 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921,973 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 38,007 | $47.88 | $1,819,885.38 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 22,443 | $52.44 | $1,176,978.25 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,012 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 23,664 | $49.55 | $1,172,463.64 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,011 | $52.44 | $105,462.87 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,791 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,121 | $47.10 | $99,899.10 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 438,658 | $52.55 | $23,051,477.90 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,681 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 51,105 | $40.56 | $2,072,910.79 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,357,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 166,189 | $34.77 | $5,778,840.24 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 339,443 | $33.23 | $11,280,166.11 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,140,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 0 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 27, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 971 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 27, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,602 Read SEC document |
| December 21, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 524 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801,027 Read SEC document |
| December 20, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife for son Disclosed balance after: 4,755 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 20, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 212 F2 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 20, 2006 Filed Feb 1, 2007 02:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801,551 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.